| Q56770452 | Q56770452 |
| Q36195237 | A Cohort Study of Myocardial Perfusion Imaging in Veteran Patients Without Symptoms: Contributing Factors and Results of Testing |
| Q89075491 | A multifunctional CT technology: Reality or illusion for patient risk assessment? |
| Q54192054 | A novel clinically relevant segmentation method and corresponding maximal ischemia score to risk-stratify patients undergoing myocardial perfusion scintigraphy. |
| Q26800543 | A review of 3D first-pass, whole-heart, myocardial perfusion cardiovascular magnetic resonance |
| Q33564475 | A study of noninvasive fractional flow reserve derived from a simplified method based on coronary computed tomography angiography in suspected coronary artery disease |
| Q54423031 | A vulnerable plaque identified on CT coronary angiography: when should we act in stable coronary artery disease? |
| Q33647497 | ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy |
| Q52845198 | Accelerated, high spatial resolution cardiovascular magnetic resonance myocardial perfusion imaging. |
| Q30435203 | Achieving an exercise workload of > or = 10 metabolic equivalents predicts a very low risk of inducible ischemia: does myocardial perfusion imaging have a role? |
| Q82372015 | Addition of atropine to submaximal exercise stress testing in patients evaluated for suspected ischaemia with SPECT imaging: a randomized, placebo-controlled trial |
| Q84140501 | Advances in percutaneous coronary intervention |
| Q37691777 | Age-related risk of major adverse cardiac event risk and coronary artery disease extent and severity by coronary CT angiography: results from 15 187 patients from the International Multisite CONFIRM Study |
| Q36687083 | All-cause mortality benefit of coronary revascularization vs. medical therapy in patients without known coronary artery disease undergoing coronary computed tomographic angiography: results from CONFIRM (COronary CT Angiography EvaluatioN For Clinic |
| Q36664605 | An Overview on Coronary Heart Disease (A Comparative Evaluation of Turkey and Europe) and Cost-effectiveness of Diagnostic Strategies |
| Q64101815 | Angina after incomplete revascularization: therapeutic solutions |
| Q37775915 | Antegrade, retrograde, and combination strategies for chronic total occlusions |
| Q38116427 | Appropriateness of percutaneous coronary intervention: a review |
| Q38192512 | Assessing clinical impact of myocardial perfusion studies: ischemia or other prognostic indicators? |
| Q38192519 | Assessing the prognostic implications of myocardial perfusion studies: identification of patients at risk vs patients who may benefit from intervention? |
| Q33627699 | Assessment of ischaemic burden in angiographic three-vessel coronary artery disease with high-resolution myocardial perfusion cardiovascular magnetic resonance imaging |
| Q30361261 | Assessment of stable coronary artery disease by cardiovascular magnetic resonance imaging: Current and emerging techniques. |
| Q34130527 | Assessment of the relationship between stenosis severity and distribution of coronary artery stenoses on multislice computed tomographic angiography and myocardial ischemia detected by single photon emission computed tomography. |
| Q92069536 | Association Between Stress Testing-Induced Myocardial Ischemia and Clinical Events in Patients With Multivessel Coronary Artery Disease |
| Q36141671 | Association of Lower Fractional Flow Reserve Values With Higher Risk of Adverse Cardiac Events for Lesions Deferred Revascularization Among Patients With Acute Coronary Syndrome |
| Q89010597 | Association of Medical Liability Reform With Clinician Approach to Coronary Artery Disease Management |
| Q50997002 | Association of biomarkers of lipid modification with functional and morphological indices of coronary stenosis severity in stable coronary artery disease. |
| Q36927242 | Automated Quantitative Nuclear Cardiology Methods |
| Q52690086 | Automated SPECT analysis compared with expert visual scoring for the detection of FFR-defined coronary artery disease. |
| Q51855976 | Automated assessment of serial SPECT myocardial perfusion images. |
| Q36060178 | Automated quantitative Rb-82 3D PET/CT myocardial perfusion imaging: normal limits and correlation with invasive coronary angiography |
| Q36480156 | Automatic alignment of myocardial perfusion PET and 64-slice coronary CT angiography on hybrid PET/CT. |
| Q50086575 | Automatic evaluation of myocardial perfusion on SPECT: Need for "Normality". |
| Q84544342 | Best way to revascularize patients with main stem and three vessel lesions: patients should undergo PCI! |
| Q52982721 | Budget impact of applying appropriateness criteria for myocardial perfusion scintigraphy: The perspective of a developing country. |
| Q38088203 | CT imaging of myocardial perfusion: possibilities and perspectives |
| Q34392078 | Cardiac CT for myocardial ischaemia detection and characterization--comparative analysis |
| Q36185492 | Cardiac CT vs. Stress Testing in Patients with Suspected Coronary Artery Disease: Review and Expert Recommendations |
| Q39686243 | Cardiac PET, CT, and MR: what are the advantages of hybrid imaging? |
| Q35214681 | Cardiac PET/CT for the evaluation of known or suspected coronary artery disease |
| Q38063172 | Cardiac autonomic imaging with SPECT tracers |
| Q87497134 | Cardiac hybrid imaging |
| Q48128845 | Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros |
| Q37904795 | Cardiovascular imaging in diabetes mellitus |
| Q55381616 | Chronic Total Occlusion Coronary Intervention: In Search of a Definitive Benefit. |
| Q30492121 | Chronic coronary artery disease: diagnosis and management |
| Q33948505 | Chronic total occlusion: To treat or not to treat. |
| Q36031834 | Chronic total occlusion: no more meta-analysis, please-a randomized clinical trial is urgently needed |
| Q39042809 | Chronic total occlusions - Current techniques and future directions |
| Q60922445 | Clinical Outcomes and Cost-Effectiveness Analysis of FFR Compared with Angiography in Multivessel Disease Patient |
| Q38371271 | Clinical Outcomes of Deferred Lesions With Angiographically Insignificant Stenosis But Low Fractional Flow Reserve. |
| Q48687775 | Clinical Outcomes of patients with coronary artery disease who underwent FFR evaluation of intermediate coronary lesionS- COFFRS study |
| Q49961115 | Clinical Relevance of Functionally Insignificant Moderate Coronary Artery Stenosis Assessed by 3-Vessel Fractional Flow Reserve Measurement. |
| Q36652110 | Clinical Role of Hybrid Imaging |
| Q26859183 | Clinical decision making with myocardial perfusion imaging in patients with known or suspected coronary artery disease |
| Q40793789 | Clinical impact of non-culprit lesions on 1-year mortality in very elderly patients with acute coronary syndrome. |
| Q27025172 | Clinical implications of cardiac hyperpolarized magnetic resonance imaging |
| Q64080878 | Clinical significance of chronic myocardial ischemia in coronary artery disease patients |
| Q37738262 | Combined anatomic and perfusion imaging of the heart |
| Q36075057 | Combined coronary angiography and myocardial perfusion by computed tomography in the identification of flow-limiting stenosis - The CORE320 study: An integrated analysis of CT coronary angiography and myocardial perfusion |
| Q41969844 | Combining noninvasive anatomical imaging with invasive functional information: an unconventional but appropriate hybrid approach |
| Q86655506 | Communication is key |
| Q59802263 | Comparative Performances of Dipyridamole and Regadenoson to Detect Myocardial Ischemia using Cardiac Cadmium-Zinc-Telluride Single-Photon Emission Computerized Tomography |
| Q37594516 | Comparative Study between Perfusion Changes and Positive Findings on Coronary Flow Reserve |
| Q26827495 | Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging |
| Q64922785 | Comparison between the summed difference score and myocardial blood flow measured by 13N-ammonia. |
| Q89872718 | Comparison of Exercise Performance and Clinical Outcome Between Functional Complete and Incomplete Revascularization |
| Q33753059 | Comparison of blood flow models and acquisitions for quantitative myocardial perfusion estimation from dynamic CT. |
| Q97645716 | Comparison of diagnostic performance between quantitative flow ratio, non-hyperemic pressure indices and fractional flow reserve |
| Q84961728 | Comparison of diagnostic performances of three different software packages in detecting coronary artery disease |
| Q50125830 | Comparison of the AHA/ACC vs ESC guidelines for management of patients with non-ST-elevation acute coronary syndromes: Are the differences clinically different? |
| Q42858835 | Comparison of the Extent and Severity of Myocardial Perfusion Defects Measured by CT Coronary Angiography and SPECT Myocardial Perfusion Imaging |
| Q50041204 | Complete revascularization determined by myocardial perfusion imaging could improve the outcomes of patients with stable coronary artery disease, compared with incomplete revascularization and no revascularization |
| Q38364639 | Complete versus incomplete coronary revascularization of patients with multivessel coronary artery disease. |
| Q100694591 | Complete versus incomplete coronary revascularization: definitions, assessment and outcomes |
| Q38206367 | Comprehensive plaque assessment by coronary CT angiography |
| Q86264103 | Computerized decision making in myocardial perfusion SPECT: The new era in nuclear cardiology? |
| Q38215340 | Contemporary overview and clinical perspectives of chronic total occlusions |
| Q93353860 | Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review |
| Q36645771 | Coronary artery disease: to cath or not to cath? When and how best to cath: those are the remaining questions |
| Q46059821 | Coronary artery spatial distribution of chronic total occlusions: Insights from a large US registry |
| Q38541750 | Coronary computed tomography angiography for the assessment of chest pain: current status and future directions |
| Q26785943 | Coronary physiology assessment in the catheterization laboratory |
| Q36795975 | Coronary plaque quantification and fractional flow reserve by coronary computed tomography angiography identify ischaemia-causing lesions |
| Q38062374 | Coronary pressure-derived fractional flow reserve in the assessment of coronary artery stenoses |
| Q62127925 | Corrected coronary opacification decrease from coronary computed tomography angiography: Validation with quantitative 13N-ammonia positron emission tomography |
| Q37729887 | Current status of cardiovascular magnetic resonance imaging in the assessment of coronary vasculature. |
| Q38432173 | Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence |
| Q98292316 | DIagnostic accuracy oF electrocardiogram for acute coronary OCClUsion resuLTing in myocardial infarction (DIFOCCULT Study) |
| Q49502415 | Deciding wisely: A case for an effective use of myocardial perfusion imaging |
| Q47192685 | Defining Quality in Cardiovascular Imaging: A Scientific Statement From the American Heart Association. |
| Q36498991 | Design and rationale of the MR-INFORM study: stress perfusion cardiovascular magnetic resonance imaging to guide the management of patients with stable coronary artery disease |
| Q61650872 | Detection of ischemia with early myocardial perfusion imaging: You see more if you watch before |
| Q35822159 | Determinants of outcome in patients with chronic ischemic left ventricular dysfunction undergone percutaneous coronary interventions |
| Q35847120 | Determinants of variations in initial treatment strategies for stable ischemic heart disease |
| Q38120658 | Diagnosing coronary artery disease with hybrid PET/CT: it takes two to tango |
| Q38300629 | Diagnosis and management of coronary allograft vasculopathy in children and adolescents. |
| Q45228893 | Diagnostic accuracy of combined coronary angiography and adenosine stress myocardial perfusion imaging using 320-detector computed tomography: pilot study. |
| Q34799114 | Diagnostic accuracy of fractional flow reserve from anatomic CT angiography |
| Q34720521 | Diagnostic performance of dual-energy CT stress myocardial perfusion imaging: direct comparison with cardiovascular MRI |
| Q46158008 | Diagnostic value of left ventricular function after adenosine triphosphate loading and at rest in the detection of multi-vessel coronary artery disease using myocardial perfusion imaging |
| Q30319078 | Different treatment options in chronic coronary artery disease: when is it the time for medical treatment, percutaneous coronary intervention or aortocoronary bypass surgery? |
| Q49961135 | Differential Clinical Outcomes Between Angiographic Complete Versus Incomplete Coronary Revascularization, According to the Presence of Chronic Kidney Disease in the Drug-Eluting Stent Era. |
| Q40017542 | Differentiation of myocardial ischemia and infarction assessed by dynamic computed tomography perfusion imaging and comparison with cardiac magnetic resonance and single-photon emission computed tomography |
| Q36410465 | Dipyridamole stress myocardial perfusion by computed tomography in patients with left bundle branch block. |
| Q37427428 | Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Myocardial imaging should not exclude patients with ischemic heart failure from |
| Q35771737 | Does ischemia burden in stable coronary artery disease effectively identify revascularization candidates? Ischemia burden in stable coronary artery disease does not effectively identify revascularization candidates |
| Q37738240 | Does myocardial perfusion imaging provide incremental prognostic information to left ventricular ejection fraction? |
| Q43455065 | Does myocardial perfusion scintigraphy predict improvement in symptoms and exercise capacity following successful elective percutaneous coronary intervention? |
| Q33167317 | Does syncope require rhythmic and non-rhythmic evaluation in patients with previous MI? |
| Q88195940 | Double Chronic Total Occlusion Recanalisation with Antegrade and Retrograde Techniques and the Use of a Novel Drug-eluting Stent with Biodegradable Polymer |
| Q54721003 | Downstream resource utilization following SPECT: Impact of age and gender. |
| Q53187415 | Downstream resource utilization following hybrid cardiac imaging with an integrated cadmium-zinc-telluride/64-slice CT device. |
| Q53265083 | Early insights of cardiac risk and treatment response with quantitative PET monitoring of coronary-specific endothelial dysfunction and myocardial perfusion reserve |
| Q38954467 | Effect of Percutaneous Coronary Intervention on Survival in Patients with Stable Ischemic Heart Disease. |
| Q40896705 | Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients |
| Q89542450 | Effects of coronary revascularization on global coronary flow reserve in stable coronary artery disease |
| Q47155873 | Efficacy of noninvasive cardiac imaging tests in diagnosis and management of stable coronary artery disease. |
| Q37702884 | Eighth Annual Mario S. Verani, MD Memorial Lecture: Nuclear cardiology in the era of multimodality cardiac imaging: Can we survive? |
| Q35156621 | Endothelial dysfunction and cardiovascular disease |
| Q47286597 | Evaluating the prognostic value of positron-emission tomography myocardial perfusion imaging using automated software to calculate perfusion defect size. |
| Q88196138 | Evidence for Benefit of Percutaneous Coronary Intervention for Chronically Occluded Coronary Arteries (CTO) - Clinical and Health Economic Outcomes |
| Q90314103 | Extent of Myocardial Ischemia on Positron Emission Tomography and Survival Benefit With Early Revascularization |
| Q38439663 | FAME 2 - The best initial strategy for patients with stable coronary artery disease: Do we have an answer at last? |
| Q39921094 | Fast myocardial perfusion imaging with 99mTc in challenging patients using conventional SPECT cameras |
| Q59689390 | Feasibility of dynamic CT-based adenosine stress myocardial perfusion imaging to detect and differentiate ischemic and infarcted myocardium in an large experimental porcine animal model |
| Q35078192 | Feasibility of high-resolution quantitative perfusion analysis in patients with heart failure |
| Q30278392 | First-pass myocardial perfusion imaging with whole-heart coverage using L1-SPIRiT accelerated variable density spiral trajectories |
| Q92218854 | Fractional Flow Reserve Assessment of Coronary Artery Stenosis |
| Q57174516 | Fractional Flow Reserve or Coronary Flow Reserve for the Assessment of Myocardial Perfusion : Implications of FFR as an Imperfect Reference Standard for Myocardial Ischemia |
| Q38113445 | Fractional flow reserve as a surrogate for inducible myocardial ischaemia |
| Q47109995 | Fractional flow reserve computed tomography in the evaluation of coronary artery disease |
| Q38355038 | Fractional flow reserve derived from coronary CT angiography in stable coronary disease: a new standard in non-invasive testing? |
| Q34455082 | Fractional flow reserve is not associated with inflammatory markers in patients with stable coronary artery disease |
| Q40581096 | Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial. |
| Q33699147 | Fractional flow reserve-guided percutaneous coronary intervention is not a valid concept |
| Q33849439 | Fractional flow reserve: a clinical perspective. |
| Q36131386 | Fractional flow reserve: the past, present and future |
| Q39821542 | Frontline diagnostic evaluation of patients suspected of angina by coronary computed tomography reduces downstream resource utilization when compared to conventional ischemia testing. |
| Q41982853 | Functional relevance of coronary artery disease by cardiac magnetic resonance and cardiac computed tomography: myocardial perfusion and fractional flow reserve |
| Q38922234 | Future of cardiac computed tomography |
| Q46752721 | Gate-keeper to coronary angiography: comparison of exercise testing, myocardial perfusion SPECT and individually tailored approach for risk stratification |
| Q34860941 | Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. |
| Q84302698 | Growing evidence that radionuclide imaging identifies management strategies that improve outcome |
| Q27002447 | Guidelines for revascularization: The evidence base matures |
| Q89096675 | Guiding coronary revascularization using PET stress myocardial perfusion imaging: The proof is in the pudding |
| Q47151397 | Harmonizing the Paradigm With the Data in Stable Coronary Artery Disease: A Review and Viewpoint |
| Q59355879 | How and When to Decide on Revascularization in Stable Ischemic Heart Disease |
| Q36008813 | How cardiologists present the benefits of percutaneous coronary interventions to patients with stable angina: a qualitative analysis |
| Q57622472 | Hybrid cardiac imaging: SPECT/CT and PET/CT. A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC) |
| Q87609459 | ISCHEMIA, to revascularize or not to revascularize |
| Q90505245 | ISCHEMIA: A Search for clarity and why we may not find it |
| Q59355685 | ISCHEMIA: Establishing the Primary End Point |
| Q37863002 | Imaging as an End Point in Ischemia Trials |
| Q26824350 | Imaging in the management of ischemic cardiomyopathy: special focus on magnetic resonance |
| Q87304974 | Immortality time and serial myocardial perfusion imaging: Only those who do not die may repeat the exam |
| Q36721469 | Impact of Aortic Stiffness Evaluated by Aortic Pulsatility on Fractional Flow Reserve. |
| Q38400209 | Impact of Follow-Up Ischemia on Myocardial Perfusion Single-Photon Emission Computed Tomography in Patients with Coronary Artery Disease. |
| Q89294401 | Impact of coronary revascularization vs medical therapy on ischemia among stable patients with or suspected coronary artery disease undergoing serial myocardial perfusion scintigraphy |
| Q46462598 | Impact of incomplete ventricular coverage on diagnostic performance of myocardial perfusion imaging |
| Q42596977 | Impact of ischemia and scar on therapeutic benefit of myocardial revascularization |
| Q30411237 | Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascu |
| Q50765741 | Impact of optimal medical therapy and percutaneous coronary intervention on patients with stable angina. |
| Q37347384 | Impact of stress testing before percutaneous coronary intervention or medical management on outcomes of patients with persistent total occlusion after myocardial infarction: analysis from the occluded artery trial. |
| Q84458473 | Importance of multimodality imaging to guide therapy in stable CAD |
| Q37886836 | Importance of residual myocardial ischemia after intervention in the genesis of cardiovascular events among patients with chronic coronary artery disease |
| Q34112453 | Improved quantification and normal limits for myocardial perfusion stress-rest change |
| Q94570689 | Improving outcomes of percutaneous coronary interventions in patients with stable ischemic heart disease |
| Q47401719 | In-stent fractional flow reserve variations and related optical coherence tomography findings: the FFR-OCT co-registration study |
| Q33604347 | Incremental value of adenosine-induced stress myocardial perfusion imaging with dual-source CT at cardiac CT angiography |
| Q37127474 | Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction |
| Q90259675 | Influence of Cardiac CT based disease severity and clinical symptoms on the diagnostic performance of myocardial perfusion |
| Q41625729 | Influence of plaque characteristics on fractional flow reserve for coronary lesions with intermediate to obstructive stenosis: insights from integrated-backscatter intravascular ultrasound analysis |
| Q38007395 | Initial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: a review of the literature |
| Q59355692 | International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design |
| Q84894454 | Interventional cardiology: How should the appropriateness of PCI be judged? |
| Q38191216 | Invasive and non-invasive fractional flow reserve index in validation of hemodynamic severity of intracoronary lesions |
| Q34319896 | Investigation route of the coronary patient in the public health system in Curitiba, São Paulo and in InCor--IMPACT study |
| Q37810400 | Is Angioplasty Able to Become the Gold Standard of Treatment Beyond Bypass Surgery for Patients With Multivessel Coronary Artery Disease? - Therapeutic Strategies for 3-Vessel Coronary Artery Disease: OPCAB vs PCI (PCI-Side) - |
| Q38091374 | Is ischemia the most powerful indicator of myocardial viability? |
| Q33582307 | Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients? |
| Q36012167 | Ischaemia change with revascularisation versus medical therapy in reduced ejection fraction |
| Q88878026 | Ischemia burden on stress SPECT MPI predicts long-term outcomes after revascularization in stable coronary artery disease |
| Q48242271 | Ischemia-based Coronary Revascularization: Beyond Anatomy and Fractional Flow Reserve. |
| Q39819658 | Ischemia-guided myocardial revascularization: the oculo-ischemic reflex. |
| Q34724467 | Ischemic burden and clinical outcome: is one 'culprit' ischemic segment by dobutamine stress magnetic resonance predictive? |
| Q59461663 | Ischämielast versus Koronarmorphologie |
| Q86980386 | It's not all in the numbers |
| Q37637815 | Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA. |
| Q37691907 | Localized spatio-temporal constraints for accelerated CMR perfusion. |
| Q98466738 | Long-Term Outcomes of Successful Revascularization for Patients With Coronary Chronic Total Occlusions: A Report of 1,655 Patients |
| Q55113414 | Long-term Survival Benefit of Statin in Patients with Coronary Chronic Total Occlusion without Revascularization. |
| Q89181742 | Long-term major adverse cardiac and cerebrovascular events (MACCE) rate : Comparison of retrograde and antegrade recanalization of chronic total coronary occlusions |
| Q38735019 | Long-term prognostic implications of myocardial perfusion imaging in octogenarians: an all-comer, cohort study |
| Q38270556 | Longitudinal myocardial blood flow gradient and CAD detection |
| Q41501131 | Lower limb arterial calcification (LLAC) scores in patients with symptomatic peripheral arterial disease are associated with increased cardiac mortality and morbidity. |
| Q42584356 | Management of Coronary Artery Calcium and Coronary CTA Findings. |
| Q37699730 | Management of stable coronary artery disease |
| Q38652030 | Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise |
| Q83181418 | Medical and Catheter-Based Therapies for Managing Stable Coronary Disease: Lessons From the COURAGE Trial |
| Q38083007 | Medical management of stable coronary atherosclerosis. |
| Q44091079 | Morphology of coronary artery lesions assessed by virtual histology intravascular ultrasound tissue characterization and fractional flow reserve |
| Q37256323 | Mortality in Medicare patients undergoing elective percutaneous coronary intervention with or without antecedent stress testing |
| Q38391213 | Multi-modality imaging for the assessment of myocardial perfusion with emphasis on stress perfusion CT and MR imaging |
| Q47714016 | Multicentre multi-device hybrid imaging study of coronary artery disease: results from the EValuation of INtegrated Cardiac Imaging for the Detection and Characterization of Ischaemic Heart Disease (EVINCI) hybrid imaging population |
| Q84819061 | Multimodality cardiac imaging |
| Q92292799 | Multimodality imaging in ischaemic heart failure |
| Q36886308 | Multiple Testing, Cumulative Radiation Dose, and Clinical Indications in Patients Undergoing Myocardial Perfusion Imaging |
| Q91686968 | Myocardial Computed Tomography Perfusion: One More Piece on The Board |
| Q59796577 | Myocardial Perfusion Scintigraphy after Percutaneous Coronary Intervention in Asymptomatic Patients: Useful or Futile? |
| Q38681519 | Myocardial blood flow: Putting it into clinical perspective |
| Q45222339 | Myocardial density analysis utilizing automated myocardial defect analysis software on resting 320-detector MDCT. |
| Q52573262 | Myocardial flow reserve derived by dynamic perfusion single-photon emission computed tomography reflects the severity of coronary atherosclerosis. |
| Q37900886 | Myocardial fractional flow reserve. Its role in guiding PCI in stable coronary artery disease |
| Q37722766 | Myocardial ischemia is a key factor in the management of stable coronary artery disease |
| Q38088206 | Myocardial perfusion imaging (MPI) is superior to the demonstration of distal collaterals in predicting cardiac events in chronic total occlusion (CTO). |
| Q46710719 | Myocardial perfusion imaging in very elderly patients with suspected coronary artery disease: never too late! |
| Q50125824 | Myocardial perfusion imaging prior to coronary revascularization: From risk stratification to procedure guidance |
| Q86568613 | Myocardial perfusion imaging to guide percutaneous revascularization of chronic total occlusions: a gate keeper to the final frontier in PCI |
| Q57618849 | Myocardial perfusion scintigraphy and echocardiography for detecting coronary artery disease in hypertensive patients: a meta-analysis |
| Q38270062 | Myocardial viability in coronary artery chronic total occlusion |
| Q27011866 | New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease |
| Q57193219 | New Trends in Quantitative Nuclear Cardiology Methods |
| Q38197125 | New insights from major prospective cohort studies with cardiac nuclear imaging |
| Q36055823 | Noise spatial nonuniformity and the impact of statistical image reconstruction in CT myocardial perfusion imaging |
| Q58769475 | Non-invasive Stenotic Renal Artery Haemodynamics by Medicine |
| Q34589468 | Non-invasive assessment of functionally significant coronary stenoses through mathematical analysis of spectral ECG components |
| Q36325459 | Non-invasive imaging in coronary artery disease including anatomical and functional evaluation of ischaemia and viability assessment. |
| Q38676391 | Noninvasive Cardiac Imaging in Patients with Known and Suspected Coronary Artery Disease: What is in it for the Interventional Cardiologist? |
| Q38357015 | Noninvasive physiologic assessment of coronary stenoses using cardiac CT. |
| Q88148760 | Novel approaches to risk stratification with semi-quantitative scoring systems in nuclear cardiology |
| Q36610219 | Nuclear cardiology practice and associated radiation doses in Europe: results of the IAEA Nuclear Cardiology Protocols Study (INCAPS) for the 27 European countries |
| Q28081835 | Nuclear cardiology: 2014 innovations and developments |
| Q99590786 | Objectifying the level of incomplete revascularization by residual SYNTAX score and evaluating the impact of incomplete revascularization on exercise tolerance in patients with coronary atherosclerotic heart disease treated by percutaneous coronary |
| Q37810399 | Off-Pump Coronary Artery Bypass vs Percutaneous Coronary Intervention - Therapeutic Strategies for 3-Vessel Coronary Artery Disease: OPCAB vs PCI (OPCAB-Side) - |
| Q38138348 | Optimal revascularization for complex coronary artery disease |
| Q92716761 | Outcomes of Chronic Total Occlusions in Coronary Arteries According to Three Therapeutic Strategies: A Meta-analysis with 6985 Patients from 8 Published Observational Studies |
| Q38021718 | PET: Is myocardial flow quantification a clinical reality? |
| Q83430233 | Patient-centered imaging |
| Q39639321 | Patients overestimate the potential benefits of elective percutaneous coronary intervention. |
| Q55344959 | Percutaneous Coronary Intervention in Chronic Total Occlusion. |
| Q88196143 | Percutaneous Treatment of Coronary Chronic Total Occlusions Part 1: Rationale and Outcomes |
| Q82791112 | Percutaneous coronary intervention in the elderly |
| Q37105989 | Perfusion cardiovascular magnetic resonance and fractional flow reserve in patients with angiographic multi-vessel coronary artery disease |
| Q33823274 | Peri-infarct ischaemia assessed by cardiovascular MRI: comparison with quantitative perfusion single photon emission CT imaging |
| Q38181440 | Perspective on CFD studies of coronary artery disease lesions and hemodynamics: a review |
| Q37156085 | Pharmacological stress cardiovascular magnetic resonance |
| Q26748665 | Physiologic Assessment of Coronary Artery Disease: Focus on Fractional Flow Reserve |
| Q26863758 | Physiologic approach for coronary intervention |
| Q61650891 | Physiologic risk assessment in stable ischemic heart disease: still superior to the anatomic angiographic approach |
| Q41024129 | Positron Emission Tomography-Determined Hyperemic Flow, Myocardial Flow Reserve, and Flow Gradient-Quo Vadis? |
| Q36622171 | Postoperative care and follow-up after coronary stenting |
| Q34255430 | Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering? |
| Q36982439 | Practice viewpoints: AICD, who and when? |
| Q38611607 | Predictive power of late gadolinium enhancement for myocardial recovery in chronic ischaemic heart failure: a HEART sub-study |
| Q90245180 | Prognostic Significance of the Residual SYNTAX Score and Ischemic Reduction Detected with Nuclear Cardiology for Prediction of Major Cardiac Events after Revascularization |
| Q45944746 | Prognostic Value of Combined Clinical and Myocardial Perfusion Imaging Data Using Machine Learning. |
| Q38378366 | Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). |
| Q47334138 | Prognostic Value of Quantitative Stress Perfusion Cardiac Magnetic Resonance. |
| Q53387669 | Prognostic estimation of coronary artery disease risk with resting perfusion abnormalities and stress ischemia on myocardial perfusion SPECT. |
| Q41169987 | Prognostic value of dipyridamole stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a mid-term follow-up study |
| Q87951520 | Prognostic value of normal stress myocardial perfusion imaging and ventricular function in Japanese patients with chronic kidney disease: a study based on the J-ACCESS-3 database |
| Q88091304 | Prognostic value of one millisievert exercise myocardial perfusion imaging in patients without known coronary artery disease |
| Q36631023 | Prognostic value of quantitative high-speed myocardial perfusion imaging |
| Q86779008 | Prognostication in the era of a new stressor for myocardial perfusion imaging |
| Q42201341 | Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score |
| Q90450424 | Quantification of vessel-specific coronary perfusion territories using minimum-cost path assignment and computed tomography angiography: Validation in a swine model |
| Q38080503 | Quantitative PET/CT measures of myocardial flow reserve and atherosclerosis for cardiac risk assessment and predicting adverse patient outcomes. |
| Q35089012 | Quantitative Upright–Supine High-Speed SPECT Myocardial Perfusion Imaging for Detection of Coronary Artery Disease: Correlation with Invasive Coronary Angiography |
| Q36142720 | Quantitative analysis of perfusion studies: strengths and pitfalls |
| Q36601740 | Quantitative assessment of myocardial perfusion abnormality on SPECT myocardial perfusion imaging is more reproducible than expert visual analysis |
| Q35163600 | Quantitative high-efficiency cadmium-zinc-telluride SPECT with dedicated parallel-hole collimation system in obese patients: results of a multi-center study |
| Q52559276 | Quantitative myocardial perfusion from static cardiac and dynamic arterial CT. |
| Q38122622 | Quantitative myocardial perfusion imaging by cardiovascular magnetic resonance and positron emission tomography |
| Q38677755 | Quantitative myocardial perfusion with stress dual-energy CT: iodine concentration differences between normal and ischemic or necrotic myocardium. Initial experience |
| Q42932911 | Radial approach and single wiring as first intentional strategies in chronic total occlusions of the left anterior descending coronary artery. |
| Q92861432 | Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia and Clinical Outcomes at One Year-Hybrid coronary REvascularization Versus Stenting or Surgery ( |
| Q98288511 | Rate Pressure Products Affect the Relationship between the Fractional Flow Reserve and Instantaneous Wave-Free Ratio |
| Q89565965 | Rationale and design of the quantification of myocardial blood flow using dynamic PET/CTA-fused imagery (DEMYSTIFY) to determine physiological significance of specific coronary lesions |
| Q24605881 | Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization |
| Q38099222 | Recent insights into the treatment of stable CAD : FFR-guided PCI vs. medical therapy |
| Q63367519 | Recovery of myocardial perfusion after percutaneous coronary intervention of chronic total occlusions is comparable to hemodynamically significant non‐occlusive lesions |
| Q38845089 | Reexamining the Efficacy and Value of Percutaneous Coronary Intervention for Patients With Stable Ischemic Heart Disease |
| Q45833492 | Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials |
| Q43439740 | Relationship between silent myocardial ischemia and coronary artery disease risk factors |
| Q88949470 | Reporting nuclear cardiology studies: Is the cup half-full or half-empty? |
| Q42650944 | Response to letter regarding article, "stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease". |
| Q37980017 | Revascularization in multivessel CAD: a functional approach |
| Q38353639 | Revascularization in patients with diabetes: PCI or CABG or none at all. |
| Q88355743 | Revascularization in stable coronary disease: evidence and uncertainties |
| Q38553176 | Revascularization vs. Medical Therapy in Stable Ischemic Heart Disease |
| Q90613103 | Revisiting the Optimal Fractional Flow Reserve and Instantaneous Wave-Free Ratio Thresholds for Predicting the Physiological Significance of Coronary Artery Disease |
| Q85008397 | Risk assessment in the era of high-speed myocardial perfusion imaging |
| Q64897172 | Risk of silent myocardial ischemia detected by single photon emission computed tomography (SPECT) among asymptomatic Chinese patients with type 2 diabetes. |
| Q89287643 | Risk stratification based on J-ACCESS risk models with myocardial perfusion imaging: Risk versus outcomes of patients with chronic kidney disease |
| Q38552516 | Role of Fractional-Flow Reserve in Guiding Percutaneous Revascularization in Stable Coronary Artery Disease. |
| Q38537093 | Role of Stress Myocardial Scintigraphy in the Evaluation of Incompletely Revascularized Post-PCI Patients |
| Q50012491 | Role of myocardial perfusion scintigraphy in octogenarians: Time for reappraisal? |
| Q30453814 | SPECT imaging for detecting coronary artery disease and determining prognosis by noninvasive assessment of myocardial perfusion and myocardial viability |
| Q34498637 | SPECT myocardial perfusion imaging as an adjunct to coronary calcium score for the detection of hemodynamically significant coronary artery stenosis |
| Q53158250 | SPECT myocardial perfusion imaging as an endpoint. |
| Q86568621 | SPECT vs CT: CT is not the first line test for the diagnosis and prognosis of stable coronary artery disease |
| Q42631738 | Screening for coronary artery disease in diabetic patients: a commentary |
| Q38024954 | Secondary revascularization after CABG surgery |
| Q47609419 | Sequential proteome alterations during genesis and progression of colon cancer |
| Q48071634 | Serial imaging and outcome prediction |
| Q90554052 | Sex Differences in the Coronary System |
| Q90669609 | Sex-Specific Association Between Coronary Artery Disease Severity and Myocardial Ischemia Induced by Mental Stress |
| Q42094629 | Shedding light on the gray zone |
| Q59789786 | Simultaneous multi slice (SMS) balanced steady state free precession first-pass myocardial perfusion cardiovascular magnetic resonance with iterative reconstruction at 1.5 T |
| Q48553059 | Sixth Annual Mario S. Verani, MD Memorial Lecture: Cardiovascular imaging--added value or added cost? |
| Q52330465 | Stenting in Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction. |
| Q37781275 | Stenting of complex lesions: an overview. |
| Q91812849 | Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 3-Year Clinical Outcomes Depending on SYNTAX Score |
| Q35793619 | Strategies for Primary Prevention of Coronary Heart Disease Based on Risk Stratification by the ACC/AHA Lipid Guidelines, ATP III Guidelines, Coronary Calcium Scoring, and C-Reactive Protein, and a Global Treat-All Strategy: A Comparative--Effective |
| Q37789188 | Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials. |
| Q37009593 | Stress CMR reduces revascularization, hospital readmission, and recurrent cardiac testing in intermediate-risk patients with acute chest pain |
| Q38449314 | Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease |
| Q87021084 | Stress protocol and accuracy of myocardial perfusion imaging: Is it better to start from the end? |
| Q36004976 | Stress testing and non-invasive coronary angiography in patients with suspected coronary artery disease: time for a new paradigm |
| Q38862940 | Successful innovation: A time for change? |
| Q38262668 | Surgical versus percutaneous revascularization in patients with multivessel coronary artery disease |
| Q53253588 | Synergistic effect of coronary artery disease risk factors on long-term survival in patients with normal exercise SPECT studies. |
| Q37738593 | Taxonomy of segmental myocardial systolic dysfunction |
| Q50621259 | Temporal analysis of regional strain rate during adenosine triphosphate stress before and after percutaneous coronary interventions. |
| Q34544809 | Tetrofosmin early time gated post-stress single-photon emission computed tomography imaging: feasibility and potential benefits |
| Q36054146 | The Impact of the Geometric Characteristics on the Hemodynamics in the Stenotic Coronary Artery |
| Q85459320 | The PROMISE of Nuclear Cardiology |
| Q35731501 | The Prevalence of Clinically Significant Ischemia in Patients Undergoing Percutaneous Coronary Intervention: A Report from the Multicenter Registry |
| Q55601885 | The Status of Stress Myocardial Perfusion Imaging Using 99mTc Pharmaceuticals in Japan: Results from a Nationwide Survey. |
| Q39264252 | The assessment of ischaemic burden: validation of a functional jeopardy score against cardiovascular magnetic resonance perfusion imaging |
| Q38683114 | The diagnostic performance of SPECT-MPI to predict functional significant coronary artery disease by fractional flow reserve derived from CCTA (FFRCT): sub-analysis from ACCURACY and VCT001 studies |
| Q53053096 | The effect of beta-blockers on the diagnostic accuracy of vasodilator pharmacologic SPECT myocardial perfusion imaging. |
| Q53827074 | The effect of percutaneous coronary revascularization on plasma N-terminal pro-B-type natriuretic peptide levels in stable coronary artery disease. |
| Q83696379 | The effect of ranolazine on the vasodilator-induced myocardial perfusion abnormality |
| Q48613788 | The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer? |
| Q33612460 | The evidence base for revascularisation of chronic total occlusions. |
| Q36982431 | The evolving role of molecular imaging for coronary artery disease: where do we stand today? |
| Q41882821 | The evolving roles of nuclear cardiology |
| Q36919239 | The importance of functional tests in personalized medicine |
| Q53473296 | The relationship between revascularization extent and the long-term prognosis of patients with stable angina pectoris and three-vessel disease treated by percutaneous coronary intervention in the era of drug-eluting stents. |
| Q35248362 | The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease |
| Q35129946 | The role of multi-slice computed tomography in stable angina management: a current perspective |
| Q34156375 | The role of radionuclide myocardial perfusion imaging for asymptomatic individuals |
| Q36383558 | The value of core lab stress echocardiography interpretations: observations from the ISCHEMIA Trial |
| Q26767316 | Theory and practical based approach to chronic total occlusions |
| Q37874991 | Three-dimensional contrast-enhanced and non-contrast-enhanced cardiac magnetic resonance imaging for the assessment of myocardial ischemic reactions: the practice of looking deeply into the myocardium |
| Q37339301 | Treating stable ischemic heart disease with percutaneous coronary intervention - The debate continues |
| Q46123303 | Treatment of chronic CAD--do the guidelines (ESC, AHA) reflect daily practice? |
| Q53627078 | Usefulness and safety of intracoronary administration of nicorandil for evaluating fractional flow reserve in Japanese patients. |
| Q93197346 | Utility of Saline-Induced Resting Full-Cycle Ratio Compared with Resting Full-Cycle Ratio and Fractional Flow Reserve |
| Q41748514 | Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial). |
| Q64956768 | Validity of inducible ischaemia as a surrogate for adverse outcomes in stable coronary artery disease. |
| Q42535948 | Value of Hybrid Imaging with PET/CT to Guide Percutaneous Revascularization of Chronic Total Coronary Occlusion |
| Q51491835 | Value of automatic patient motion detection and correction in myocardial perfusion imaging using a CZT-based SPECT camera. |
| Q38775694 | Variable temporal sampling and tube current modulation for myocardial blood flow estimation from dose-reduced dynamic computed tomography |
| Q30434323 | Vasodilator stress perfusion CMR imaging is feasible and prognostic in obese patients |
| Q89770838 | Vessel-specific coronary perfusion territories using a CT angiogram with a minimum cost path technique and its direct comparison to the American Heart Association 17-segment model |
| Q35580975 | Vulnerable plaque features on coronary CT angiography as markers of inducible regional myocardial hypoperfusion from severe coronary artery stenoses. |
| Q49352355 | What is this image? 2017: Image 4 result : Improvement of ischemia with statin therapy |
| Q36021757 | What's Age Got to do with it? A Review of Contemporary Revascularization in the Elderly |
| Q95466231 | [Cardiac imaging in (asymptomatic) diabetic patients] |
| Q53137053 | [Diagnostic work-up of coronary artery disease: Clinical value of different imaging methods]. |
| Q87193477 | [Differential therapy in coronary heart disease] |
| Q26828766 | 2013 ACCF/ACR/ASE/ASNC/SCCT/SCMR appropriate utilization of cardiovascular imaging in heart failure: a joint report of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Foundation Appropriate |